Silicon Republic May 3, 2024
Laura Varley

Integration of Nvidia’s microservices and AWS will enable healthcare and life sciences companies to tackle complex challenges in drug discovery and digital health.

US chip giant Nvidia yesterday (2 May) announced the integration of its NIM cloud-native microservices with Amazon Web Services (AWS), in what is a significant development for the advancement of digital health and drug discovery.

VP of healthcare for the company Kimberly Powell made the announcement at the AWS Life Sciences Leader Symposium in Boston.

The collaboration represents a potentially transformative leap for the healthcare sector as it will give access to a vast collection of AI tools, including “foundation models for drug discovery, medical imaging and genomics, backed by enterprise-grade security and support”.

Professionals can...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Pharma, Pharma / Biotech, Technology
In AI Businesses Trust—But Are Still Accountable For Integrity Lapses
Visualizing ChatGPT’s Rising Dominance
Sam Altman Speaks On Tech Progress
AI Makes Echocardiography Faster, More Accessible
AI-Driven Dark Patterns: How Artificial Intelligence Is Supercharging Digital Manipulation

Share This Article